Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion type Assertion NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_head.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion description "[Collectively, our results indicate that PTEN loss defines a PI3K/AKT-dependent GCB DLBCL subtype that is addicted to PI3K and MYC signaling and suggest that pharmacologic inhibition of PI3K might represent a promising therapeutic approach in these lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_provenance.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion evidence source_evidence_literature NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_provenance.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion SIO_000772 23840064 NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_provenance.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion wasDerivedFrom befree-20150227 NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_provenance.
- NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_assertion wasGeneratedBy ECO_0000203 NP625159.RActwkDOxFxGifz7OUpOp5utAxOzF1yrfE0H2DspucAhI130_provenance.